Normal view MARC view ISBD view

Leaflet modification with the ShortCut TM device to prevent coronary artery obstruction during TAVR. [Review] - 2024

Available in print through MWHC library: 2002 - present

Transcatheter heart valve (THV) procedures require careful planning and consideration to prevent coronary artery obstruction (CAO), which poses a significant and potentially life-threatening condition, especially in patients undergoing valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR). Despite identifying predictors of CAO and utilization of computed tomography and inputting THV features, a significant uncertainty remains in predicting CAO. The ShortCut TM device (Pi-Cardia, Rehovot, Israel) was purposefully designed to modify the leaflets in patients undergoing TAVR, especially prior to ViV procedures, to overcome the risk for CAO. This review aims to detail the device's objectives, structure, procedural steps, the available clinical data, and future directions for its intended utilization in the structural arena for the prevention of CAO. Copyright © 2024. Published by Elsevier Inc.


English

ISSN: 1878-0938

Standard No.: S1553-8389(24)00098-8 [pii]

Subjects--Topical Terms: --Automated
IN PROCESS -- NOT YET INDEXED

Subjects--Geographic Terms:
MedStar Heart & Vascular Institute
MedStar Washington Hospital Center

Index Terms--Occupation:
Advanced Cardiac Catheterization Research Fellowship
Interventional Cardiology Fellowship

Index Terms--Function:
Journal Article
Review